Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Huestis MA; Chemistry and Drug Metabolism, IRP, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA.; University of Maryland School of Medicine, Baltimore, Maryland, USA.
Subjects: Cannabinoids/Cannabinoids/Cannabinoids/*adverse effects ; Designer Drugs/Designer Drugs/Designer Drugs/*adverse effects ; Psychotropic Drugs/Psychotropic Drugs/Psychotropic Drugs/*adverse effects
-
Source:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2017 Feb; Vol. 101 (2), pp. 152-157.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print Cited Medium: Internet
Record details
-
Authors :
Rabin RA; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Schizophrenia and Addictions Divisions, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Subjects: Cannabinoids/Cannabinoids/Cannabinoids/*toxicity ; Marijuana Abuse/Marijuana Abuse/Marijuana Abuse/*complications ; Psychoses, Substance-Induced/Psychoses, Substance-Induced/Psychoses, Substance-Induced/*epidemiology
-
Source:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2017 Feb; Vol. 101 (2), pp. 197-199. Date of Electronic Publication: 2016 Aug 13.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:
Record details